PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Years of mechanism: 2010 2011 2012 2013 2014 2015 2016 2017 2018
TB/HIV care and treatment. Includes supporting TB/HIV activities in the private sector as part of Private Public Mix interventions; updating TB/HIV guidelines and interventions; and training health care providers in these interventions, including strengthening recording and reporting on collaborative activities. Support will also be given to the University of Namibia TB/HIV Resource Centre. The program will ensure all 34 hospitals have written and monitored TB Infection Control plans which are implemented.
Continuing Activity
Estimated Budget = $300,000
Programmatic Management of drug resistant tuberculosis (PMDT). Funding will be provided for regular support and supervision to hospitals managing DR TB, including the funding to address DR TB among the San community who are disproportionately affected by the disease. 60 health workers (doctors, nurses, pharmacists, pharmacy assistants, social workers and occupational therapists) will be trained on clinical management of DR TB. The training will introduce health workers to new diagnosis algorithms aimed at early DR TB case identification. Quarterly DR TB review meetings will continue to be funded to strengthen and verify data recording and reporting.
Health System Strengthening. 350 health workers will be trained on the new guidelines (a comprehensive curriculum covering TB/HIV, DR TB, Infection control, pediatric TB care, Community TB care and Medicines management). Zonal quarterly review meetings will continue to be funded with support and supervision to those regions needing special attention. Staff at the national level will be supported to attend local and international trainings to enhance management skills and increase TB/HIV and DR/TB knowledge.
Estimated Budget = $150,000
TB Care and Treatment. Support for community TB care will continue to cover the whole of Erongo and Karas regions through support to field promoters. World TB commemorations will be funded under this activity including the Tuberculosis Communication for Behavioral Improvement (TBCOMBI) which among other things supports GRN TB Lifestyle Ambassador quarterly meetings and GRN-mandated incentives. Refresher trainings for field promoters will be funded under this activity.
Estimated Budget = $200,000
ADDITIONAL DETAIL:
KNCV tuberculosis foundation's main thrust is to provide technical assistance for tuberculosis control through knowledge transfer. This contributes to sustained capacity building throughout all levels of care. The result has been that TB care has improved across all levels in the years KNCV has been working in Namibia. KNCV works to ensure that institutional guidelines on community TB care are in line with international standards; disseminates these guidelines; and trains health workers and lay people (field promoters and NGO workers) in implementing these guidelines. KNCV also supports operations research; enables staff and management to attend international conferences; and provides TA through periodic consultant visits to the National TB program.
TB/HIV care and treatment:
KNCV will continue to provide technical assistance to the National Tuberculosis and Leprosy Program (NTLP) to ensure strengthening and implementation of TB/HIV collaborative activities. KNCV will ensure promotion of policies that ensure early diagnosis of TB in HIV infected individuals as well as an integrated approach to TB and HIV treatment. Intensified case finding strategies at HIV counseling and testing (HCT) sites, including PMTCT centers, health facilities and within the community, shall be tailored to address gender inequalities to care and will also ensure that children who are TB contacts to ensure are traced and put on Isoniazid Preventive Therapy (IPT) or TB treatment, as appropriate. Through strengthening the TB/HIV working groups at all levels, KNCV will ensure implementation and recording of TB screening among HIV clients attending ART clinics and at every contact with health facilities. Given the high Isoniazid resistance in Namibia, KNCV will be engaging the local and international communities to tailor implementation of IPT in Namibia to suit the high level of primary and secondary INH resistance in the country. It should be tailored to be given to those who will benefit from it.
Programmatic Management of drug resistant tuberculosis (PMDT):
KNCV has supported the initiation of PMDT and wishes to continue strengthening the implementation of the program. Given the high HIV prevalence in Namibia; it is essential that strategies that ensure early diagnosis (using rapid molecular diagnostic methods) are promoted and implemented while infection control in health facilities is addressed and infection control strategies at home and community level are promoted. KNCV will also strengthen DR TB surveillance to ensure data for decision making is accurate and timely reported.
Health System Strengthening:
KNCV tuberculosis foundation is embedded in the MOH and provides direct skills transfer along with ensuring increased staff deployment at national, regional and district level who are mentored directly by KNCV consultants. This will ensure continuity of care when the support of KNCV comes to an end. KNCV will ensure training of all health care providers (doctors, nurses, pharmacists, pharmacy assistants, field promoters, TB NGO leaders) on the new guidelines to ensure knowledge transfer and standard TB care across the whole country. Quarterly review meetings will continue to be supported to consolidate the surveillance system that has been the flagship of care in Namibia. TA will also be provided for a comprehensive Human Resource Development (HRD) policy to ensure a consistent and integrated approach to HRD including the required skill sets, motivational support, location, job description, and evaluations.
TB Care and Treatment (DOTS strengthening):
Namibia has attained a high case detection rate of over 70% in new smear positive cases and a treatment success rate of 82%. This has been attained through a number of strategies including Community based TB care (CBTBC). KNCV will ensure continued support of CBTBC to the Erongo region and support standardization of CBTBC provided under R10 of Global Fund. KNCV will continue to ensure early diagnosis and access to care and treatment for those who are most disadvantaged, for example, people living in informal settlements around urban areas, etc. KNCV will collaborate with GRN to ensure that laboratory services are up to international standards to ensure universal access to free diagnostic services of the highest standard.
